Treatment with dupilumab, an injection therapy approved for certain inflammatory disorders, was found to completely heal blistering in a woman…
Articles by Patricia Inácio, PhD
Wounds in people with dystrophic epidermolysis bullosa (DEB) are complex and dynamic, and current categories to define such wounds…
Avicanna‘s cannabidiol (CBD) cream formulation for skin improved wound healing in 55% of children and adolescents with epidermolysis…
In children with epidermolysis bullosa (EB) with airway involvement, a new strategy using both cell and gene therapy showed promise…
The 7th annual Plunge for Elodie is set to raise $500,000 for epidermolysis bullosa (EB) research, which would bring…
Recessive dystrophic epidermolysis bullosa (RDEB) is linked with high care costs, particularly for severe forms of the…
The presence of loose joints, or hypermobility, contributes to the impaired walking ability seen in many children with epidermolysis…
Abeona Therapeutics is preparing to request U.S. approval of EB-101, a cell therapy candidate for treating recessive…
New study findings show how the complement system C5aR2 protein at the surface of neutrophils, a type of immune cell,…
Colitis, an inflammation of the large intestine (colon), may develop in rare cases in people with recessive dystrophic epidermolysis…
InMed Pharmaceuticals has completed enrollment for a Phase 2 trial testing INM-755, an investigational cannabinol cream, for people with…
Gold weight implants were safely implanted under the eyelids of a woman with recessive dystrophic epidermolysis bullosa (RDEB), according…